Published : Jul-2017
No. of Pages : 141
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Needle Free Injections Overview 7
3 Products under Development 8
3.1 Needle Free Injections - Pipeline Products by Stage of Development 8
3.2 Needle Free Injections - Pipeline Products by Territory 9
3.3 Needle Free Injections - Pipeline Products by Regulatory Path 10
3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date 11
3.5 Needle Free Injections - Ongoing Clinical Trials 12
4 Needle Free Injections - Pipeline Products under Development by Companies 13
4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development 13
4.2 Needle Free Injections - Pipeline Products by Stage of Development 14
5 Needle Free Injections Companies and Product Overview 15
5.1 B. Braun Melsungen AG Company Overview 15
5.1.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Boston Scientific Corp Company Overview 16
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Crossject SA Company Overview 17
5.3.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Enable Injections, LLC Company Overview 21
5.4.1 Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Eternity Healthcare Inc. Company Overview 22
5.5.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 EuroJet Medical Kft. Company Overview 23
5.6.1 EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Glide Pharmaceutical Technologies Ltd Company Overview 24
5.7.1 Glide Pharmaceutical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Inovio Pharmaceuticals Inc Company Overview 25
5.8.1 Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Medical International Technologies (Mit Canada) Inc Company Overview 30
5.9.1 Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 PharmaJet Inc Company Overview 35
5.10.1 PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Teva Pharmaceutical Industries Ltd Company Overview 39
5.11.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
6 Needle Free Injections- Recent Developments 40
6.1 Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell 40
6.2 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced 40
6.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 40
6.4 Jun 15, 2017: Consort Medical: Full year results 42
6.5 Jun 13, 2017: Needle-free Injection Linked to Increasing Workplace Flu Shot Compliance 43
6.6 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 44
6.7 Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors 44
6.8 May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 45
6.9 May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results 45
6.10 May 11, 2017: Teva Reports First Quarter 2017 Financial Results 46
6.11 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 50
6.12 May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results 51
6.13 May 04, 2017: Zogenix Reports First Quarter 2017 Financial Results 53
6.14 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 53
6.15 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio 55
6.16 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 56
6.17 Apr 26, 2017: Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer 57
6.18 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 57
6.19 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 59
6.20 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 59
6.21 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 60
6.22 Mar 31, 2017: B. Braun continues its sales and earnings growth 60
6.23 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 62
6.24 Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 62
6.25 Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results 64
6.26 Mar 09, 2017: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 65
6.27 Mar 07, 2017: PharmaJet partners with Serum Institute to Launch Needle-Free MMR Vaccine 67
6.28 Mar 06, 2017: CROSSJECT receives authorization to conduct Zeneo Midazolam bioequivalence study 67
6.29 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 68
6.30 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 69
6.31 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 70
6.32 Feb 22, 2017: Change in the B. Braun Management Board 71
6.33 Feb 21, 2017: Valeritas Reports Fourth Quarter and Full Year 2016 Financial Results 71
6.34 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 72
6.35 Feb 14, 2017: Expanded Vaccine offering for PharmaJet Needle-free Device 73
6.36 Feb 13, 2017: Teva Reports Full Year and Fourth Quarter 2016 Financial Results 73
6.37 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 80
6.38 Feb 09, 2017: Terumo Announces Change of Executive Officers 80
6.39 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 81
6.40 Feb 06, 2017: Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman 82
6.41 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 84
6.42 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 85
6.43 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 87
6.44 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 90
6.45 Jan 31, 2017: Terumo Opens a Branch in Yangon 90
6.46 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 90
6.47 Jan 10, 2017: Milestone Certification Achieved For Eternity Healthcare's Lenis Device 91
6.48 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 92
6.49 Jan 06, 2017: Teva Provides 2017 Financial Outlook 92
6.50 Jan 05, 2017: Zogenix Announces CFO Transition 93
6.51 Dec 22, 2016: Teva Reaches Settlement with Government on FCPA 95
6.52 Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges 95
6.53 Dec 14, 2016: Consort Medical: Directorate Change 96
6.54 Dec 13, 2016: Eternity Healthcare Moves to Next Stage Regulatory Approval Phase with Lenis 96
6.55 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 97
6.56 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 97
6.57 Dec 05, 2016: Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson 99
6.58 Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors 101
6.59 Nov 25, 2016: Consort Medical: CFO Appointment 101
6.60 Nov 15, 2016: Teva Reports Third Quarter 2016 Results 102
6.61 Nov 14, 2016: BioSyent Pharma Launches New Urgent Care Product 104
6.62 Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results 105
6.63 Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results 106
6.64 Nov 09, 2016: Aradigm Announces Third Quarter 2016 Financial Results 107
6.65 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 108
6.66 Nov 08, 2016: Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results 109
6.67 Nov 08, 2016: Teva Announces Appointment of New Chief Legal Officer 110
6.68 Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer 111
6.69 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 112
6.70 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 113
6.71 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 115
6.72 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 118
6.73 Oct 04, 2016: PharmaJet Needle-Free Flu Shots Offered in Workplace Health Clinics 119
6.74 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 119
6.75 Sep 22, 2016: Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors 120
6.76 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development 121
6.77 Aug 30, 2016: PharmaJet Collaborates with World Health Organization 121
6.78 Aug 17, 2016: Consort Medical Announces Directorate Change 122
6.79 Aug 16, 2016: Valeritas Appoints Erick J. Lucera as Chief Financial Officer 122
6.80 Aug 10, 2016: Aradigm Announces Second Quarter 2016 Financial Results 123
6.81 Aug 10, 2016: Valeritas Reports Second Quarter 2016 Financial Results 124
6.82 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 125
6.83 Aug 09, 2016: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results 127
6.84 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 128
6.85 Aug 04, 2016: Teva Reports Second Quarter 2016 Results 128
6.86 Aug 03, 2016: NIH using PharmaJet in DNA Vaccine Clinical Trial for Zika Virus 133
6.87 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 134
6.88 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 135
7 Appendix 138
7.1 Methodology 138
7.2 About GlobalData 141
7.3 Contact Us 141
7.4 Disclaimer 141
1.1 List of Tables
Table 1: Needle Free Injections - Pipeline Products by Stage of Development 8
Table 2: Needle Free Injections - Pipeline Products by Territory 9
Table 3: Needle Free Injections - Pipeline Products by Regulatory Path 10
Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date 11
Table 5: Needle Free Injections - Ongoing Clinical Trials 12
Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development 13
Table 7: Needle Free Injections - Pipeline Products by Stage of Development 14
Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Needle-Free System - Product Status 15
Table 10: Needle-Free System - Product Description 15
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: JetTouch System - Overactive Bladder - Product Status 16
Table 13: JetTouch System - Overactive Bladder - Product Description 16
Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status 17
Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description 18
Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status 18
Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description 18
Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status 19
Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description 19
Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status 19
Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description 20
Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status 20
Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description 20
Table 25: Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 26: Enable Injector - Product Status 21
Table 27: Enable Injector - Product Description 21
Table 28: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: Multi Channel Needle-Free Injection Device - Product Status 22
Table 30: Multi Channel Needle-Free Injection Device - Product Description 22
Table 31: EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 32: E-Jet 500 Needle Free Injector - Product Status 23
Table 33: E-Jet 500 Needle Free Injector - Product Description 23
Table 34: Glide Pharmaceutical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 24
Table 35: Glide SDI - Product Status 24
Table 36: Glide SDI - Product Description 24
Table 37: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 38: Iject R Pre-Filled Syringe - Product Status 25
Table 39: Iject R Pre-Filled Syringe - Product Description 26
Table 40: Intradermal Pen Injector - Product Status 26
Table 41: Intradermal Pen Injector - Product Description 26
Table 42: Intradermal Syringe - Product Status 27
Table 43: Intradermal Syringe - Product Description 27
Table 44: Mega Jet - Product Status 27
Table 45: Mega Jet - Product Description 28
Table 46: Multi-Port Orifices - Product Status 28
Table 47: Multi-Port Orifices - Product Description 28
Table 48: Needle-Free Vaccine Delivery Device - Product Status 29
Table 49: Needle-Free Vaccine Delivery Device - Product Description 29
Table 50: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 51: MED-JET MBX Injector - Product Status 30
Table 52: MED-JET MBX Injector - Product Description 31
Table 53: MESO-JET - Product Status 31
Table 54: MESO-JET - Product Description 31
Table 55: MIT-H-III - Product Status 32
Table 56: MIT-H-III - Product Description 32
Table 57: MIT-H-IV-1 - Product Status 32
Table 58: MIT-H-IV-1 - Product Description 33
Table 59: MIT-H-IV-5 - Product Status 33
Table 60: MIT-H-IV-5 - Product Description 33
Table 61: MIT-H-VI Dental Injector - Product Status 34
Table 62: MIT-H-VI Dental Injector - Product Description 34
Table 63: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 64: Tropis - Product Status 35
Table 65: Tropis - Product Description 35
Table 66: Variable Volume Drug Delivery Device - Product Status 36
Table 67: Variable Volume Drug Delivery Device - Product Description 36
Table 68: PharmaJet Inc - Ongoing Clinical Trials Overview 37
Table 69: Tropis - A Pragmatic Trial to Quantitatively and Qualitatively Assess Different Techniques for the ID Administration of Fractional Dose IPV in a Campaign Setting in the Gambia 38
Table 70: Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 71: MicroDose Needlefree System - Product Status 39
Table 72: MicroDose Needlefree System - Product Description 39
Table 73: Glossary 140
1.2 List of Figures
Figure 1: Needle Free Injections - Pipeline Products by Stage of Development 8
Figure 2: Needle Free Injections - Pipeline Products by Territory 9
Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path 10
Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date 11
Figure 5: Needle Free Injections - Ongoing Clinical Trials 12
